For three intense days, Seville was the setting for the 3rd Plenary Meeting of the European CARAMEL project, a key event that brought together more than 30 health professionals, researchers and technology providers. The event, organised by the Andalusian Health Service (SAS) and the Andalusian Public Foundation for Health Research Management in Seville (FISEVI), marked a milestone on the road to the launch of the CARAMEL Observational Study (CARAMEL-OS) scheduled for the first quarter of 2026.

Three very productive days

The first day focused on practical training with clinical teams and the use of medical devices and digital technologies that will support the study. The second day provided an overview of the first year of collaboration between the 25 partners, with progress on the CARAMEL-WOMEN study and a workshop on cardiovascular risk stratification. The third day addressed communication, the exploitation of results, advances in artificial intelligence and the presentation of the project’s digital platform, concluding with practical workshops.

A project with international impact

The CARAMEL Observational Study will be launched in 2026 and will be open to women aged between 40 and 60 in Gipuzkoa and Seville (Spain), Athens (Greece), Vilnius (Lithuania), Zagreb (Croatia) and Bogota (Colombia). Its objective is to advance cardiovascular prevention in women by integrating clinical data, digital technologies and artificial intelligence models.

With this meeting, the consortium reaffirms its commitment to innovation and women’s health, consolidating CARAMEL as a benchmark project in Europe and Latin America.

Biokeralty and Keralty in CARAMEL

Biokeralty and Keralty are actively involved in the project, each with specific roles within the consortium:

Keralty, as a clinical partner, is a key player in the project. It participates in the design and co-creation activities (WP4 DESIGN), the retrospective study (WP5 DATA) and the prospective and intervention studies (WP11-WP13 STUDIES). Biokeralty focuses on economic and impact research to validate the cost-effectiveness and integration of CARAMEL solutions into healthcare systems, as well as providing support to Keralty.

Discover how innovation and international collaboration are transforming cardiovascular prevention for women: visit the CARAMEL website and social media and be part of the change towards more inclusive and sustainable health.

https://www.caramel-project.eu/
https://www.linkedin.com/company/caramel-eu-project
https://www.facebook.com/CaramelEUProject